Daneng Li, M.D., a City of Hope associate professor in the Department of Medical Oncology & Therapeutics Research commented:
“The results show that our novel oncolytic virus — both alone or in combination with immunotherapy — has the ability to control various cancer types previously resistant to other treatment options, and these early results provide patients with hope of a new treatment option for cancers refractory to standard treatment.”
GLTAH
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $89.60M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $140.7K | 11.61M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 9000852 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6923007 | 25 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |